(Q33263686)

English

Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Giuseppe Palmieri

1

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Giuseppe Castello

object named as

Giuseppe Castello

12

0 references

Corrado Caracò

object named as

Corrado Caracò

7

0 references

Paolo Antonio Ascierto

13

object named as

Paolo A Ascierto

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

8

object named as

Ester Simeone

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Nicola Mozzillo

10

object named as

Nicola Mozzillo

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Antonio Daponte-Codina

9

object named as

Antonio Daponte

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Francesco Tanda

5

object named as

Francesco Tanda

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Antonio Giuseppe Maria Cossu

4

object named as

Antonio Cossu

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Sabrina M.R. Satriano

2

object named as

Sabrina M R Satriano

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

3

object named as

Mario Budroni

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Sergio Canzanella

6

object named as

Sergio Canzanella

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Giuseppe Comella

11

object named as

Giuseppe Comella

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

language of work or name

0 references

publication date

15 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

266

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

15 November 2006

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Quantification of melanoma mRNA markers in sentinel nodes: pre-clinical evaluation of a single-step real-time reverse transcriptase-polymerase chain reaction assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657030

28 July 2018

The natural course of cutaneous melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657030

28 July 2018

Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657030

28 July 2018

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657030

28 July 2018

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657030

28 July 2018

The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657030

28 July 2018

Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657030

28 July 2018

Landscaping the cancer terrain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657030

28 July 2018

Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657030

28 July 2018

The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657030

28 July 2018

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657030

28 July 2018

The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657030

28 July 2018

A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657030

28 July 2018

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657030

28 July 2018

Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657030

28 July 2018

Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-266

21 January 2018

Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-266

21 January 2018

Melanoma-associated antigens as messenger RNA detection markers for melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657030

31 October 2018

Polymerase Chain Reaction-Based Detection of Circulating Melanoma Cells as an Effective Marker of Tumor Progression

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-266

21 January 2018

Adjuvant therapy of cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-266

21 January 2018

ONCOGENESIS: Landscaping the Cancer Terrain

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-266

21 January 2018

Molecular staging of malignant melanoma: correlation with clinical outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1657030

31 October 2018

Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17107608

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of the detection of circulating malignant cells by reverse transcriptase-polymerase chain reaction in long-term clinically disease-free melanoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17107608

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/17107608

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/17107608

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular and prognostic classification of advanced melanoma: a multi-marker microcontamination assay of peripheral blood stem cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17107608

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognosis of metastatic melanoma: no correlation of tyrosinase mRNA in bone marrow and survival time

1 reference

https://pubmed.ncbi.nlm.nih.gov/17107608

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the use of tyrosinase-specific and melanA/MART-1-specific reverse transcriptase-coupled--polymerase chain reaction to detect melanoma cells in peripheral blood samples from 299 patients with malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17107608

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tyrosinase mRNA in Blood of Patients With Melanoma Treated With Adjuvant Interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/17107608

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic role of detection of circulating melanoma cells in the blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/17107608

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/17107608

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/17107608

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17107608

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17107608

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-6-266

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33263686&oldid=2195178563"